BD Intraosseous Infusion System— 510(k) K203193

Substantially Equivalent

Bard Access Systems, Inc(Bas)[Wholly-Owned Subsidiary of Bd]

FDA 510(k) clearance K203193 for BD Intraosseous Infusion System, Substantially Equivalent on 2021-03-04. Applicant: Bard Access Systems, Inc(Bas)[Wholly-Owned Subsidiary of Bd]. Device class: 2.

Clearance details

Applicant
Bard Access Systems, Inc(Bas)[Wholly-Owned Subsidiary of Bd]
Product code
Code MHC
Device class
Class 2
Regulation
21 CFR 880.5570
Advisory panel
General Hospital
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Salt Lake Ciy,, UT, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code MHC

view all

Recalls naming K203193

K-number listed on FDA's recall record

Matched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K203193.

Data sourced from openFDA. This site is unofficial and independent of the FDA.